Rephonic
Artwork for Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Continuous Glucose Monitoring
Diabetes
Insulin Pumps
Diabetes Management
Eversense 365
FDA Approval
Medicare Coverage
Diabetes Technology
Ascensia
Libre 3
Ilit Insulin Pump
Dexcom G6
Dexcom G7
Omnipod 5
Tidepool
SGLT2 Inhibitors
Hypercortisolism
Catalyst Trial
Dexcom Stelo
Obesity

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please... more

PublishesDailyEpisodes172Founded4 years ago
Number of ListenersCategories
ScienceMedicineHealth & Fitness

Listen to this Podcast

Artwork for Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Latest Episodes

In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, breakdown recent trial news from the 2 most popular incretin therapies: semaglutide and tirzepatide. First, hosts breakdown the November 24, 2025 announcement from Novo Nordisk di... more

In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review two major developments in diabetes care: the forthcoming 15-day Dexcom G7 continuous glucose monitor (CGM) and significant new price reductions for semaglutide as Ozempic a... more

In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, meet in person at the Diabetes Technology Meeting (DTM) in San Francisco to discuss the latest clinical and regulatory advances surrounding semaglutide. Key Episode Timestamps 00:... more

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!

In this episode, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, explore 3 significant developments shaping diabetes care: a novel glucose-sensing techno... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine PodcastThe Curbsiders Internal Medicine Podcast
unPAUSED with Dr. Mary Claire Haver
unPAUSED with Dr. Mary Claire HaverAudacy | Mary Claire Haver, MD
The Huddle: Conversations with the Diabetes Care Team
The Huddle: Conversations with the Diabetes Care TeamAssociation of Diabetes Care & Education Specialists
The Peter Attia Drive
The Peter Attia DrivePeter Attia, MD

Recent Guests

Bob Vigersky
Chief Medical Officer at Medtronic Diabetes
Medtronic
Episode: What's New at Medtronic Diabetes With Bob Vigersky, MD
Carol Levy
Professor in the Department of Medicine's Division of Endocrinology, Diabetes, and Bone Disease, and in the Department of Obstetrics, Gynecology, and Reproductive Science
Icahn School of Medicine at Mount Sinai
Episode: Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD
Rachael Sood
Nurse practitioner and CDCES, owner of the Diabetes Collective
The Diabetes Collective
Episode: The Diabetes Collective, with Rachael Sood, RN, MSN, APRN
Jay Shubrook
A primary care diabetologist with a background in family medicine.
American College of Diabetology
Episode: Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
Conan Tu
An adult internist and primary care provider with a focus on diabetes care.
American College of Diabetology
Episode: Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
John Buse
Professor at the University of North Carolina School of Medicine, diabetes clinician and clinical trialist.
University of North Carolina School of Medicine
Episode: CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD
Kevin Sayer
CEO of Dexcom who has been pivotal in advancing diabetes monitoring technology.
Dexcom
Episode: Updates from Dexcom at ADA 2025, with Kevin Sayer
Melanie Davies
Professor of Diabetes Medicine from Leicester, UK, and PI on the REDEFINE trials.
University of Leicester
Episode: REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Timothy Garvey
Endocrinologist with a focus on obesity treatment.
University of Alabama at Birmingham
Episode: REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD

Hosts

Diana Isaacs
Co-host of the podcast with a focus on technology, therapeutics, and real-world perspectives in diabetes management. Diana brings clinical insights and research expertise from her roles in endocrinology.
Natalie Bellini
Co-host of the podcast specializing in the exploration of diabetes technologies and treatment options. Natalie offers a comprehensive view of clinical advancements and patient care strategies.

Reviews

4.8 out of 5 stars from 22 ratings
  • Excellent podcast!

    Highly recommend for people living with diabetes! Thanks so much for the technology updates and diabetes management info you provide! :)

    Apple Podcasts
    5
    AEB9857
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The hosts are praised for their expertise and the practical relevance of the information shared.
Feedback emphasizes the importance of the technological advancements discussed, making complex medical information accessible.
Listeners commend the podcast for providing valuable insights and updates in diabetes management.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: What were the primary outcomes of the REDEFINE trials?
The primary outcomes were the mean percentage weight loss and the percentage of patients achieving greater than 5% weight loss.
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: Can you share a little about how THE REDEFINE 2 trial was designed?
REDEFINE 2 only had two arms, comparing CagriSema against placebo, focusing on patients with type 2 diabetes.
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: How were the side effects for the CagriSema group?
The side effects for the CagriSema group were similar to those for Semaglutide alone, with manageable gastrointestinal symptoms.
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
Q: Can you tell us a little bit about the numbers and results in REDEFINE 1?
Patients in REDEFINE 1 achieved a 22.4% weight loss with CagriSema, significantly outperforming the other arms.
INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD
Q: Can you share a little bit about the Inhale-3 study and what the goals were?
The study aimed to assess the effectiveness of combining inhaled insulin with long-acting insulin for diabetes management across different user profiles.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This podcast provides a comprehensive overview of developments in diabetes technology, therapeutics, and related healthcare perspectives. Hosted by two knowledgeable professionals, each episode discusses a range of topics including advancements in diabetes medication, innovative management technologies, and significant research findings that directly impact patient care. Listeners can expect insights on real-world applications of new treatments, discussions around the challenges faced in diabetes management, and interviews with experts in the field, making it a valuable resource for healthcare providers and individuals interested in the latest trends and treatments in diabetes care.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

How many episodes of this podcast are there?

this podcast launched 4 years ago and published 172 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Bob Vigersky
2. Carol Levy
3. Rachael Sood
4. Jay Shubrook
5. Conan Tu
6. John Buse
7. Kevin Sayer
8. Melanie Davies

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days